Skip to main content
MapleLMS Implementation
Conferences and Meetings 904. Outcomes Research: Hemoglobinopathies: Poster II

904. Outcomes Research: Hemoglobinopathies: Poster II

Short name: 904. Outcomes Research: Hemoglobinopathies: Poster II
Course start date: 11/05/2025

Sections

General
0 activities

Characterizing Death in Sickle Cell Disease in a National EHR Database: A Population Analysis
Efficacy and Safety of Zoledronic Acid in Sickle Cell Disease Associated Bone Disorders :Single Centre Experience
Exploring What Makes Sickle Cell Patients Feel Cared for & Opportunities for Improvement through a Qualitative Lens
Health-Related Communication in Adolescents and Young Adults with Sickle Cell Disease
Impact and Aggravating Factors of Chronic Pain in Sickle Cell Disease: Results of the Analysis of Promis® Questionnaires and the Metabolomic Profile of Brazilian Adult Patients
Ketamine Use in Hospitalized Children and Young Adults with Sickle Cell Disease
Large Scale Community-Based Sickle Cell Surveillance in an Aboriginal Population from Western India
Low Uptake of FDA-Approved Medications for Sickle Cell Disease Amongst the Adult Medicaid Population in North Carolina
Prioritizing Mental Health in Sickle Cell Disease: Implementing Routine Psychological and Neurocognitive Assessments in a Comprehensive Sickle Cell Clinic
Prospective Biopsychosocial Impacts of Stress and Disease Stigma Among Adolescents and Young Adults with Sickle Cell Disease
Qualitative Interview Study to Characterize the Treatment Experiences of Participants with Sickle Cell Disease and Assess Perceptions of Red Blood Cell Transfusions
Sickle Cell Disease Mortality and Census Tract-Level Social Vulnerability – California Sickle Cell Data Collection Program, 2016-2022
Use of Chronic Blood Transfusion Therapies and Pharmaceutical Disease Modifying Treatments in Sickle Cell Disease: A Retrospective Cohort Analysis (2014-2021)